ONCY News and Press, Oncolytics Biotech Inc. From 05/13/21

Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference PR Newswire Fireside chat to take place on Wednesday, May 19 at 5:25 pm ET SAN DIEGO and CALGARY, AB , May 13, 2021 /...

Oncolytics Biotech (ONCY): Q1 GAAP EPS of -C$0.13.Cash and cash equivalents of C$50.36MPress Release For further details see: Oncolytics Biotech reports Q1 results

Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results PR Newswire - AWARE-1 clinical data validate clinical development strategy by confirming pelareorep's anti-tumor mechanism of action known to be associated with imp...

Oncolytics Biotech® Announces Annual General Meeting Canada NewsWire Management will also provide its annual corporate update after the conclusion of the meeting SAN DIEGO, Calif. and CALGARY, AB , April 30, 2021 /CNW/ -- Oncolytics Biotech ...

Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting PR Newswire SAN DIEGO and CALGARY, AB , April 29, 2021 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today anno...

Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study PR Newswire - Pelareorep and atezolizumab synergize the anti-cancer immune response in HR+/HER2- breast cancer patients - Pelareorep alone and with checkpoint blockade converts tumors ...

Top Biotech Penny Stocks To Watch If you are looking to invest in penny stocks, there has never been a better time than now. By definition, the term “ penny stock ” refers to stocks that trade under $5. Thanks to this, the low cost provides an interesting entry opportu...

Oncolytics Biotech® to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference PR Newswire SAN DIEGO and CALGARY, Alberta , April 8, 2021 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (T...

Today, we take a look at an 'off the radar' development concern named Oncolytics Biotech. The company's primary drug candidate is advancing in several trials in combination with various checkpoint inhibitors targeting different forms of tumors. A full analysis follows in the parag...

Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors Webinar will take place Monday April 12, 2021 at 2:00 pm ET Canada...